Home

Amfibiu Amper ucide marker tumoral m 8560 3 deturnare Bijuterie Abandon

Dual effect of radiotherapy related concomitant cardiovascular diseases in  non‐small cell lung cancer - Mo - Cancer Medicine - Wiley Online Library
Dual effect of radiotherapy related concomitant cardiovascular diseases in non‐small cell lung cancer - Mo - Cancer Medicine - Wiley Online Library

Microbiome Assisted Tumor Microenvironment: Emerging Target of Breast  Cancer - ScienceDirect
Microbiome Assisted Tumor Microenvironment: Emerging Target of Breast Cancer - ScienceDirect

Dataset for the reporting of carcinoma of the exocrine pancreas:  recommendations from the International Collaboration on Cancer Reporting  (ICCR) - Verbeke - 2021 - Histopathology - Wiley Online Library
Dataset for the reporting of carcinoma of the exocrine pancreas: recommendations from the International Collaboration on Cancer Reporting (ICCR) - Verbeke - 2021 - Histopathology - Wiley Online Library

Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine  prostate cancer | Nature Communications
Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer | Nature Communications

Frontiers | A Competing Risk Analysis Model to Determine the Prognostic  Value of Isolated Tumor Cells in Axillary Lymph Nodes for T1N0M0 Breast  Cancer Patients Based on the Surveillance, Epidemiology, and End
Frontiers | A Competing Risk Analysis Model to Determine the Prognostic Value of Isolated Tumor Cells in Axillary Lymph Nodes for T1N0M0 Breast Cancer Patients Based on the Surveillance, Epidemiology, and End

Variants of Gallbladder Carcinoma | SpringerLink
Variants of Gallbladder Carcinoma | SpringerLink

Driver Mutation Variant Allele Frequency in Circulating Tumor DNA and  Association with Clinical Outcome in Patients with Non–Small Cell Lung  Cancer and EGFR- and KRAS-Mutated Tumors - The Journal of Molecular  Diagnostics
Driver Mutation Variant Allele Frequency in Circulating Tumor DNA and Association with Clinical Outcome in Patients with Non–Small Cell Lung Cancer and EGFR- and KRAS-Mutated Tumors - The Journal of Molecular Diagnostics

Microsatellite instability is associated with worse overall survival in  resectable colorectal liver metastases - The American Journal of Surgery
Microsatellite instability is associated with worse overall survival in resectable colorectal liver metastases - The American Journal of Surgery

Aberrant Methylation of the CHFR Gene is Frequently Detected in  Non-invasive Colorectal Cancer
Aberrant Methylation of the CHFR Gene is Frequently Detected in Non-invasive Colorectal Cancer

Breast tumor stiffness instructs bone metastasis via maintenance of  mechanical conditioning
Breast tumor stiffness instructs bone metastasis via maintenance of mechanical conditioning

Near-infrared photoimmunotherapy targeting GPR87: Development of a  humanised anti-GPR87 mAb and therapeutic efficacy on a lung cancer mouse  model - eBioMedicine
Near-infrared photoimmunotherapy targeting GPR87: Development of a humanised anti-GPR87 mAb and therapeutic efficacy on a lung cancer mouse model - eBioMedicine

Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect  Sufficient for Curing Cancer? | Bioconjugate Chemistry
Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer? | Bioconjugate Chemistry

The engineered CD80 variant fusion therapeutic davoceticept combines  checkpoint antagonism with conditional CD28 costimulation for anti-tumor  immunity | Nature Communications
The engineered CD80 variant fusion therapeutic davoceticept combines checkpoint antagonism with conditional CD28 costimulation for anti-tumor immunity | Nature Communications

Frontiers | Dynamic Responses of Microglia in Animal Models of Multiple  Sclerosis
Frontiers | Dynamic Responses of Microglia in Animal Models of Multiple Sclerosis

Differential Immune-Related Microenvironment Determines Programmed Cell  Death Protein-1/Programmed Death-Ligand 1 Blockade Efficacy in Patients  With Advanced NSCLC - Journal of Thoracic Oncology
Differential Immune-Related Microenvironment Determines Programmed Cell Death Protein-1/Programmed Death-Ligand 1 Blockade Efficacy in Patients With Advanced NSCLC - Journal of Thoracic Oncology

IJMS | Free Full-Text | Diagnostic Value of MAML2 Rearrangements in  Mucoepidermoid Carcinoma | HTML
IJMS | Free Full-Text | Diagnostic Value of MAML2 Rearrangements in Mucoepidermoid Carcinoma | HTML

The 2022 World Health Organization Classification of Tumours of the Urinary  System and Male Genital Organs—Part A: Renal, Penile, and Testicular  Tumours - European Urology
The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours - European Urology

Protein Profiling of Human Breast Tumor Cells Identifies Novel Biomarkers  Associated with Molecular Subtypes - Molecular & Cellular Proteomics
Protein Profiling of Human Breast Tumor Cells Identifies Novel Biomarkers Associated with Molecular Subtypes - Molecular & Cellular Proteomics

Cytidine deaminase deficiency in tumor cells is associated with sensitivity  to a naphthol derivative and a decrease in oncometabolite levels |  SpringerLink
Cytidine deaminase deficiency in tumor cells is associated with sensitivity to a naphthol derivative and a decrease in oncometabolite levels | SpringerLink

Cancerul gastric
Cancerul gastric

The 2016 WHO Classification of Tumours of the Urinary System and Male  Genital Organs—Part B: Prostate and Bladder Tumours - European Urology
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part B: Prostate and Bladder Tumours - European Urology

Hepatitis E virus infects brain microvascular endothelial cells, crosses  the blood–brain barrier, and invades the central nervous system | PNAS
Hepatitis E virus infects brain microvascular endothelial cells, crosses the blood–brain barrier, and invades the central nervous system | PNAS

Laboratorija - BIOHEMIJSKI TUMOR-MARKERI BIOCHEMICAL TUMOUR-MARKERS *srb*  Tumorski markeri su specifični biomolekuli koje stvara organizam kao  metabolički ili imunološki odgovor zdrave ćelije na prisutnost maligne  ćelije ili ih produkuju same maligne ...
Laboratorija - BIOHEMIJSKI TUMOR-MARKERI BIOCHEMICAL TUMOUR-MARKERS *srb* Tumorski markeri su specifični biomolekuli koje stvara organizam kao metabolički ili imunološki odgovor zdrave ćelije na prisutnost maligne ćelije ili ih produkuju same maligne ...